Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

COVID-19 Updates: 2nd Infection, Is Metformin Helpful, Rule-Breakers, Depression

COVID-19 Updates: 2nd Infection, Is Metformin Helpful, Rule-Breakers, Depression

Research continues to expand our knowledge of the novel coronavirus (SARS-CoV-2) and the COVID-19 Pandemic it has caused. Let us review the latest developments published.

Is there a risk of catching COVID-19 a second time?

A contact-tracing study in Guangzhou, China reported that, depending on the setting and disease severity, among close contacts of people diagnosed with COVID-19, the risk of secondary transmission was below 4%.

The study examined 3410 close contacts of 391 people diagnosed with COVID-19 in Guangzhou between January and March. For this purpose, researchers identified symptomatic patients (those showing symptoms) presenting to a healthcare facility, or people in close contact with those diagnosed with COVID-19.

The results showed that 127 close contacts (3.7%) became infected. Of these 127 people, 8 (6.3%) were asymptomatic (without symptoms). Among 119 symptomatic patients, 20 (16.8%) had mild symptoms, 87 (73.1%) moderate symptoms and 12 (10.1%) severe or critical symptoms.

Homes, public transport, healthcare settings, entertainment venues and workplaces were included to determine how risk varied by contact location. Secondary infection risk was highest among contacts living in the same household, at 10.3%, followed by healthcare settings at 1.0% and public transport at 0.1%.

Does metformin reduce deaths from COVID-19?

Available data suggest that the drug widely used for type 2 diabetes, metformin, may reduce the risk of death from COVID-19. However, researchers say that conducting the randomized (random patient enrollment) studies needed to prove this possibility is not very feasible.

In a study whose results were published in July 2020, researchers reported that metformin use was associated with around a 70% reduction in the risk of death in more than 600 patients with diabetes and a COVID-19 diagnosis.

An expert researcher assessed the study in these words: “Although people taking metformin tend to have better outcomes, in my view it is still unclear whether metformin is truly a miracle drug or whether using it more frequently among people without any health problem would cause harm ”.

In another report on the subject, a study published in The Lancet Rheumatology reported that the use of rituximab to reduce B cell numbers could target the acquired immune response and benefit patients with severe COVID-19 (a form of immune suppression). Researchers say more research is needed to establish the results, while describing the initial findings as extremely exciting.

How is our behavior changing during the pandemic? Why do some people not follow the rules?

Although rule-breaking is not new, behavioral scientists say that in the COVID-19 outbreak it has been exacerbated by cultural, demographic and psychological factors.

Restrictions and social distancing measures introduced worldwide during the COVID-19 outbreak are reshaping lives. Some topics from a question-and-answer interview with human behavioral scientists during the outbreak;

What factors make some people reject the rules while others follow them?

The main factor is individualism and collectivism. Jay Van Bavel, an associate professor of psychology at New York University, says: “In some countries, individuality is highly prominent, and they offer living conditions suited to expressing a sense of identity individually.” People living in individualistic cultures reject the rules and ignore public health workers' calls for behavior changes to reduce risks.

Expert Michael Sander says: “For example, if you say that wearing a mask will help protect others, people in cultures where individuality is prominent care less about this.” Conversely, in collective cultures, people are more inclined to do what is best for the group.

Why is it difficult to follow social distancing rules?

Van Bavel: “Our bodies and brains tend to seek closeness with other people. The rules we must follow during the COVID-19 pandemic are completely at odds with these instincts. People therefore find social distancing rules extremely difficult to follow. This also shows that local outbreaks may arise in nightclubs, religious ceremonies or parties.”

As the pandemic continues, concerns are growing that its effects on mental health will persist.

A published study showed that mental health screening results indicated a serious increase in depression, anxiety, psychosis and suicidal tendencies. By the end of June, more than 169,000 additional participants were reported to be experiencing moderate to severe depression or anxiety compared with participants before the outbreak. In June alone, 18,000 additional participants were found to be at risk of psychosis. 

Researchers say the problem is more serious than imagined and that the greatest problem is seen in adults younger than 25. Around 90% of the patient groups are diagnosed with moderate to severe depression, while 80% are diagnosed with moderate to severe anxiety.

A survey found that 35% of adults with symptomatic coronavirus infection had not returned to their normal state of health in interviews conducted 2-3 weeks after testing. Researchers say psychiatric conditions such as depression have a major influence on prolonged recovery.

Does convalescent (recovered) plasma therapy work?

Researchers at Mayo Clinic reported strong indications that blood plasma obtained from patients who had recovered after a COVID-19 diagnosis helps other patients recover. These results are not conclusive evidence, however, and there are concerns about whether a clear answer can be obtained during this process.

- Related topic: What Should We Know About Blood Products and CONVALESCENT PLASMA Treatment During the Coronavirus Outbreak?

In the United States, more than 64,000 patients received convalescent plasma therapy, a century-old approach used to eliminate influenza and measles before vaccines. Results suggest that this method works for some infections, though not all.

To date, there is no robust evidence that this method is successful against coronavirus or, if it is, how it should be used. Preliminary data from 35,000 coronavirus patients treated with plasma, however, signal that it may be successful. Researchers also emphasize lower death rates among patients given plasma within three days of diagnosis and the detection of very high antibody levels in people's plasma.

Does the infection or treatment cause skin lesions?

Although SARS-CoV-2 infection has been associated with a range of skin conditions, dermatologists also note that these may result from side effects of drugs used to treat COVID-19.

Researchers say they continue to find it difficult to diagnose the skin lesions observed in people with COVID-19 because it has not yet been established whether the lesions are related to the virus.

FDA approves new saliva test

The FDA authorized a new saliva-based COVID-19 test to reduce the cost of tests used to detect SARS-CoV-2 and the time needed to obtain results.

- Related topic: How Is Coronavirus Testing Performed? What Are PCR and Rapid Diagnostic Test Types?

Designed by the Yale School of Public Health and called SalivaDirect, the test requires no special test tube or sample-collection equipment. Researchers involved in the study announced that they would provide the required laboratories with the procedural steps needed to perform it. Since no special equipment is needed, the number of tests that can readily be implemented is expected to increase over the next few weeks.

Sources

1. Cite this: COVID-19 Update: Trump’s New Adviser,Plasma Potential - Medscape - Aug 17, 2020.

2. COVID-19 Update: Comparison With 1918 Flu, Secondary Transmission - Medscape - Aug 14, 2020.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

COVID-19 Updates: 2nd Infection, Is Metformin Helpful, Rule-Breakers, Depression

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy